Developed through Harvard’s Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat disease

Injectable sponge-like gel enhances the quantity and quality of T-cells

New advances selectively suppress damaged cells, allowing for transplants without chemotherapy or radiation

FUSION symposium brings two spheres together to lend insights to action